Interview with Gediminas Smaily

More information

Media type:

Video

Interview with Gediminas Smaily from the Lithuanian IBD patient association during the EFCCA General Assembly.

Category:

EFCCA events

Starting Date:

Monday, 17 July, 2017

EFCCA Magazine 2/2022

Type: Article

Our latest issue of the EFCCA Magazine is out! You will find information about our latest activities, news from our members and other exciting articles related to IBD and the patient community. ...

Thank you!

Type: Article

EFCCA...

Added Value of Patient Engagement

Type: Article

Interesting article published by the European Medicine Agency looking into the added value of Patient Engagement.

...

IBD has no age - World IBD Day 2022

Type: Article

Purple Talk Watch our Patient Testimonials

This year, for World IBD Day 2022, EFCCA would like to raise awareness...

EFCCA YOUTH Academy

Type: Article

We have launched our Youth Academy with the aim to increase the representativeness of the youth group, create a cohesive group of leaders of tomorrow and to empower young representatives.

...

Projects

The Yellowstone Crohn’s Disease Clinical Research Program

Type: Clinical Trial

The YELLOWSTONE Program is a series of Phase 3 clinical studies for people with moderately to severely active Crohn’s disease. These studies will evaluate the safety and effectiveness of an oral...

GLADIATOR Ulcerative Colitis (UC) Study

Type: Clinical Trial

Are you suffering from Ulcerative Colitis (UC)?

The GLADIATOR UC Team is looking for people with moderately active UC to join a clinical research study assessing an...

Break the Silence! World IBD Day 2021

Type: Project

This year, for ...

OPTIMISE Study

Type: Clinical Trial

Is there a better way to optimise disease control for patients with ulcerative colitis? A new study aims to find out

Achieving and maintaining effective control of...

HCP Training on Biosimilars

Type: Project

EFCCA has been collaborating with Medscape on a training session about biosimilars and the patients' perspective which...